Intuitive for Robotic Surgery

J&J enters US robotic surgery market

J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery system will take meaningful share from the market leader.

Cryptopolitan · 1d

Johnson & Johnson wins FDA authorization for its robotic surgery device

MSN · 1d

J&J enters US robotic surgery market after device gets marketing authorization

· 1d

J&J gets a big win on its new robotic surgical system — plus, a flood of earnings

Johnson & Johnson got a big regulatory win , with the FDA approving its Ottava Robotic surgical system for multiple general procedures.

· 1d

Johnson & Johnson’s robotic surgery device gets US marketing authorization

· 9h

J&J Receives FDA Approval for Soft Tissue Surgical Robot

· 1d

Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today

Investors should note that Ottava features robotic arms integrated directly into the operating table, reducing floor footprint by as much as 50% compared to the conventional boom-and-car systems.

· 1d

Johnson & Johnson Gets FDA OK for Ottava Robotic Surgical System

· 1d

J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod

MassDevice

Intuitive showcases AI for surgical robotics, telesurgery capabilities

Intuitive (Nasdaq:ISRG) today outlined its vision for the use of AI in surgical robotics to address key healthcare challenges.

J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

J&J’s Ottava clearance knocked Intuitive's shares lower, but recurring revenue and surgeon switching costs suggest the market overreacted.

Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot

Johnson & Johnson (JNJ) stock gains as FDA clears the company's Ottava surgical robot, pressuring rivals Intuitive Surgical (ISRG) and Medtronic (MDT). Read more here.

Nasdaq

Intuitive Releases Studies Highlighting Impact of Robotic-Assisted Surgery on Access and Patient Outcomes in Minimally Invasive Care

Intuitive, a leader in robotic-assisted surgery (RAS), announced two studies showing that RAS improves access to high-quality care and enhances patient outcomes, particularly in areas with limited medical resources. Published in respected medical journals ...

14h

Intuitive Shares Vision for an AI-Enabled Future of Healthcare

Company outlines five-layer AI framework to help address healthcare’s biggest challenges and demonstrates real-time telesurgical collaboration between California and Georgia Intuitive Shares Vision for an AI-Enabled Future of Healthcare Intuitive will outline its vision for how artificial intelligence (AI) can help shape the future of surgical care and address key healthcare challenges at the Society of Robotic Surgery's (SRS) annual conference in Hollywood,

17don MSN

Prediction: Intuitive Surgical Will Be Worth $500 Billion by 2031 -- Here's Why

The company has the elements that make a fantastic long-term investment.

MedTech Dive

Intuitive ties Q2 procedure softness to ACA subsidy expirations

Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.